Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC

NCT02394015 · clinicaltrials.gov ↗
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Grupo Español de Investigación en Cáncer de Ovario

Collaborators